[ExI] good bexarotene article

[Jeff Davis]

2012/2/11 Stefano Vaj <stefano.vaj at gmail.com>:

> ...the mainstream view remains just the
> opposite, and perhaps increasingly so.

The compelling nature of the Alzheimer's predicament and the looming
baby boom demographic will likely dispose of **that** mainstream view.

Or an effective AMA and FDA-approved Alzheimer's therapy will emerge
to moot the issue.

Best outcome:  an effective off-label (ie non-FDA "owned") Alzheimer's
therapy that becomes the champion example for patients' rights.

Best, Jeff Davis

    "Everything's hard till you know how to do it."
                               Ray Charles